
Michael C. Wilson
Examiner (ID: 16269, Phone: (571)272-0738 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1638, 1633, 1632 |
| Total Applications | 1637 |
| Issued Applications | 556 |
| Pending Applications | 303 |
| Abandoned Applications | 820 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14535099
[patent_doc_number] => 20190203171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => HUMAN LAMBDA LIGHT CHAIN MICE
[patent_app_type] => utility
[patent_app_number] => 16/298308
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16298308
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/298308 | HUMAN LAMBDA LIGHT CHAIN MICE | Mar 10, 2019 | Abandoned |
Array
(
[id] => 17633305
[patent_doc_number] => 11344008
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-05-31
[patent_title] => Production of human DNaseI in erythrocytes of transgenic non-human mammal using erythroid-specific promoter
[patent_app_type] => utility
[patent_app_number] => 16/295155
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 5173
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16295155
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/295155 | Production of human DNaseI in erythrocytes of transgenic non-human mammal using erythroid-specific promoter | Mar 6, 2019 | Issued |
Array
(
[id] => 16554940
[patent_doc_number] => 20210000088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => TRANSGENIC CHICKEN THAT PRODUCES HUMAN ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 16/977430
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977430
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977430 | TRANSGENIC CHICKEN THAT PRODUCES HUMAN ANTIBODIES | Mar 4, 2019 | Pending |
Array
(
[id] => 16126477
[patent_doc_number] => 10696984
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Packaging cell for making a pseudotyped lentivirus
[patent_app_type] => utility
[patent_app_number] => 16/293151
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 35
[patent_no_of_words] => 29380
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16293151
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/293151 | Packaging cell for making a pseudotyped lentivirus | Mar 4, 2019 | Issued |
Array
(
[id] => 20241216
[patent_doc_number] => 12421525
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Conjugates comprising AAVs and CAS9 polypeptides
[patent_app_type] => utility
[patent_app_number] => 16/976720
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 3014
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16976720
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/976720 | Conjugates comprising AAVs and CAS9 polypeptides | Feb 27, 2019 | Issued |
Array
(
[id] => 16513254
[patent_doc_number] => 20200392512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => NUCLEOTIDE SEQUENCES ENCODING PEPTIDE LINKERS
[patent_app_type] => utility
[patent_app_number] => 16/975422
[patent_app_country] => US
[patent_app_date] => 2019-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16975422
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/975422 | NUCLEOTIDE SEQUENCES ENCODING PEPTIDE LINKERS | Feb 25, 2019 | Abandoned |
Array
(
[id] => 16269091
[patent_doc_number] => 20200270578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => Method for Producing Mesenchymal Stem Cells from Neonatal Stem Cells
[patent_app_type] => utility
[patent_app_number] => 16/286482
[patent_app_country] => US
[patent_app_date] => 2019-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16286482
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/286482 | Method for Producing Mesenchymal Stem Cells from Neonatal Stem Cells | Feb 25, 2019 | Abandoned |
Array
(
[id] => 14439625
[patent_doc_number] => 20190177685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => Multipotential Expanded Mesenchymal Precursor Cell Progeny (MEMP) and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/284878
[patent_app_country] => US
[patent_app_date] => 2019-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16284878
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/284878 | Multipotential Expanded Mesenchymal Precursor Cell Progeny (MEMP) and Uses Thereof | Feb 24, 2019 | Abandoned |
Array
(
[id] => 16728111
[patent_doc_number] => 20210095258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => POST PARTUM TISSUE-DERIVED INDUCED PLURIPOTENT STEM CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/971936
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971936
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/971936 | POST PARTUM TISSUE-DERIVED INDUCED PLURIPOTENT STEM CELLS AND USES THEREOF | Feb 21, 2019 | Abandoned |
Array
(
[id] => 14868591
[patent_doc_number] => 20190284537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => WNT PATHWAY STIMULATION IN REPROGRAMMING SOMATIC CELLS WITH NUCLEAR REPROGRAMMING FACTORS
[patent_app_type] => utility
[patent_app_number] => 16/279991
[patent_app_country] => US
[patent_app_date] => 2019-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16279991
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/279991 | WNT PATHWAY STIMULATION IN REPROGRAMMING SOMATIC CELLS WITH NUCLEAR REPROGRAMMING FACTORS | Feb 18, 2019 | Abandoned |
Array
(
[id] => 19778522
[patent_doc_number] => 12227546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Plasmid encoding a c-terminal fragment of paraspeckle component 1 for treating tumors
[patent_app_type] => utility
[patent_app_number] => 16/970350
[patent_app_country] => US
[patent_app_date] => 2019-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7647
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970350
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/970350 | Plasmid encoding a c-terminal fragment of paraspeckle component 1 for treating tumors | Feb 11, 2019 | Issued |
Array
(
[id] => 14743881
[patent_doc_number] => 20190255114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => STORAGE OF PLATELETS
[patent_app_type] => utility
[patent_app_number] => 16/273340
[patent_app_country] => US
[patent_app_date] => 2019-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16273340
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/273340 | STORAGE OF PLATELETS | Feb 11, 2019 | Abandoned |
Array
(
[id] => 17378307
[patent_doc_number] => 11236305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-01
[patent_title] => Method for isolating and culturing adipose stromal cells
[patent_app_type] => utility
[patent_app_number] => 16/273059
[patent_app_country] => US
[patent_app_date] => 2019-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 29
[patent_no_of_words] => 11831
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16273059
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/273059 | Method for isolating and culturing adipose stromal cells | Feb 10, 2019 | Issued |
Array
(
[id] => 14342823
[patent_doc_number] => 20190153384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => HUMAN LAMBDA LIGHT CHAIN MICE
[patent_app_type] => utility
[patent_app_number] => 16/269477
[patent_app_country] => US
[patent_app_date] => 2019-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16269477
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/269477 | HUMAN LAMBDA LIGHT CHAIN MICE | Feb 5, 2019 | Abandoned |
Array
(
[id] => 16189535
[patent_doc_number] => 20200230384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => METHOD FOR INTRANASAL STEM CELL THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/253681
[patent_app_country] => US
[patent_app_date] => 2019-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 437
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16253681
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/253681 | METHOD FOR INTRANASAL STEM CELL THERAPY | Jan 21, 2019 | Abandoned |
Array
(
[id] => 14620099
[patent_doc_number] => 20190223416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => CANINE GENOME EDITING
[patent_app_type] => utility
[patent_app_number] => 16/254260
[patent_app_country] => US
[patent_app_date] => 2019-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4197
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16254260
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/254260 | CANINE GENOME EDITING | Jan 21, 2019 | Abandoned |
Array
(
[id] => 16655291
[patent_doc_number] => 20210051927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => TRANSGENIC RAINBOW SHARK
[patent_app_type] => utility
[patent_app_number] => 16/961195
[patent_app_country] => US
[patent_app_date] => 2019-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16961195
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/961195 | Transgenic rainbow shark | Jan 9, 2019 | Issued |
Array
(
[id] => 14621939
[patent_doc_number] => 20190224337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => INDUCIBLE EXPRESSION CASSETTE, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/235559
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6706
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16235559
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/235559 | INDUCIBLE EXPRESSION CASSETTE, AND USES THEREOF | Dec 27, 2018 | Abandoned |
Array
(
[id] => 15210517
[patent_doc_number] => 20190367945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => METHOD OF TREATING TYPE I DIABETES USING AN AAV VECTOR ENCODING URACORTIN 2
[patent_app_type] => utility
[patent_app_number] => 16/233970
[patent_app_country] => US
[patent_app_date] => 2018-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16233970
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/233970 | Method of treating type I diabetes using an AAV vector encoding uracortin 2 | Dec 26, 2018 | Issued |
Array
(
[id] => 16673381
[patent_doc_number] => 20210062144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => PLACENTA-DERIVED CELL-CONDITIONED MEDIUM FOR INDUCING DEDIFFERENTIATION INTO INDUCED PLURIPOTENT STEM CELLS FROM SOMATIC CELLS AND METHOD FOR INDUCING DEDIFFERENTIATION USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/956798
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956798
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/956798 | PLACENTA-DERIVED CELL-CONDITIONED MEDIUM FOR INDUCING DEDIFFERENTIATION INTO INDUCED PLURIPOTENT STEM CELLS FROM SOMATIC CELLS AND METHOD FOR INDUCING DEDIFFERENTIATION USING THE SAME | Dec 20, 2018 | Abandoned |